323
Views
10
CrossRef citations to date
0
Altmetric
Articles

Bavachinin mitigates DMH induced colon cancer in rats by altering p53/Bcl2/BAX signaling associated with apoptosis

, , &

References

  • Bird RP. 1987. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:147–151. doi:10.1016/0304-3835(87)90157-1.
  • Bird RP, Good K. 2000. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett. 112–113:395–402.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. doi:10.3322/caac.21492.
  • Brighenti E, Calabrese C, Liguori G, Giannone FA, Trerè D, Montanaro L, Derenzini M. 2014. Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Oncogene. 33:4396–4406. doi:10.1038/onc.2014.1.
  • Chen X, Yang Y, Zhang Y. 2013. Isobavachalcone and bavachinin from Psoraleae fructus modulate Aβ42 aggregation process through different mechanisms in vitro. FEBS Lett. 587:2930–2935. doi:10.1016/j.febslet.2013.07.037.
  • Chen X, Shen Y, Liang Q, Flavell R, Hong Z, Yin Z, Wang M. 2014. Effect of bavachinin and its derivatives on T cell differentiation. Int Immunopharm. 19:399–404. doi:10.1016/j.intimp.2014.01.022.
  • Colussi D, Brandi G, Bazzilo F, Ricciardeillo L. 2013. Molecular pathways involved in colon cancer: implications for disease behaviour and prevention. Int J Mol Sci. 14:16365–16385. doi:10.3390/ijms140816365.
  • Daaboul HE, Daher CF, Bodman-Smith K, Taleb RI, Shebaby WN, Boulos J, Dagher C, Mroueh MA, El-Sibai M. 2017. Antitumor activity of β-2-himachalen-6-ol in colon cancer is mediated through its inhibition of the PI3K and MAPK pathways. Chem-Biol Interact. 275:162–170. doi:10.1016/j.cbi.2017.08.003.
  • Dai Y, Ma T, Ge M, Li J, Huo Q, Li HM, Zhang X, Liu H, Wu CZ. 2016. Enzymatic synthesis of novel bavachinin glucoside by UDP‐glycosyltransferase. J Chin Chem Sci. 63:376–378. doi:10.1002/jccs.201500497.
  • Feng L, Luo H, Xu Z, Yang Z, Du G, Zhang Y, Yu L, Hu K, Zhu W, Tong Q, Chen K, Guo F, Huang C, Li Y. 2016. Bavachinin, as a novel natural pan-PPAR agonist, exhibits unique synergistic effects with synthetic PPAR-γ and PPAR-α agonists on carbohydrate and lipid metabolism in db/db and diet-induced obese mice. Diabetologia. 59:1276–1286. doi:10.1007/s00125-016-3912-9.
  • Fischer AH, Jacobson KA, Rose J, Zeller R. 2008. Hematoxylin and eosin staining of tissue and cell sections. C S Harb Protoc. 6:1–3.
  • Garber J, Barbee R, Bielitzki J. 2010. Guide for the care and use of laboratory animals. Washington (DC): National Academic Press.
  • Guo S, Shan S, Jin X, Li Z, Li Z, Zhao L, An Q, Zhang W. 2015. Water stress proteins from Nostoc commune Vauch exhibit anti-colon cancer activities in vitro and in vivo. J Agric Food Chem. 63:150–159. doi:10.1021/jf503208p.
  • Hajrezaie M, Hassandarvish P, Moghadamtousi SZ, Gwaram NS, Golbabapour S, Najihussien A, Almagrami AA, Zahedifard M, Rouhollahi E, Karimian H, Fani S, Kamalidehghan B, Majid NA, Ali HM, Abdulla MA. 2014. Chemopreventive evaluation of a Schiff base derived copper (II) complex against azoxymethane-induced colorectal cancer in rats. PLoS One. 9:e91246. doi:10.1371/journal.pone.0091246.
  • Kakkar P, Das B, Viswanthan PN. 1984. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys. 21:130–132.
  • Karthik Kumar V, Vennila S, Nalini N. 2009. Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer. Food Chem Toxicol. 47:309–315. doi:10.1016/j.fct.2008.11.017.
  • Kim YJ, Lee H, Park E, Shim SH. 2009. Inhibition of human 20S proteasome by compounds from seeds of Psoralea corylifolia. Bull Kor Chem Soc. 30:1867–1869.
  • Kuntz S, Wenzel U, Daniel H. 1999. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr. 38:133–142. doi:10.1007/s003940050054.
  • Lee MH, Kim JY, Ryu JH. 2005. Prenylflavones from Psoralea corylifolia inhibit nitric oxide synthase expression through the inhibition of I-κB-α degradation in activated microglial cells. Biol Pharm Bull. 28:2253–2257. doi:10.1248/bpb.28.2253.
  • Lee SW, Yun BR, Kim MH, Park CS, Lee WS, Oh HM, Rho MC. 2012. Phenolic compounds isolated from Psoralea corylifolia inhibit IL-6-induced STAT3 activation. Planta Med. 78:903–906. doi:10.1055/s-0031-1298482.
  • Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell. 88:323–331. doi:10.1016/S0092-8674(00)81871-1.
  • Li Y, Zhang T, Chen GY. 2018. Flavonoids and colorectal cancer prevention. Antioxidants. 7:187–214. doi:10.3390/antiox7120187.
  • McLellan KR, Bird RP. 1988. Aberrant crypts: potential preneoplastic lesions in aberrant crypt foci and colon cancer the murine colon. Can Res. 48:6187–6192.
  • Moreno I, Pichardo S, Jos A, Gómez-Amores L, Mate A, Vazquez CM, Cameán AM. 2005. Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to microcystin-LR administered intraperitoneally. Toxicon. 45:395–402. doi:10.1016/j.toxicon.2004.11.001.
  • Narendhirakannan RT, Subramanian S, Kandaswamy M. 2005. Free radical scavenging activity of Cleome gynandra L. leaves on adjuvant induced arthritis in rats. Mol Cell Biochem. 276:71–80. doi:10.1007/s11010-005-3234-6.
  • Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 70:461–477. doi:10.1021/np068054v.
  • Pandurangan AK, Kumar SA, Dharmalingam P, Ganapasam S. 2014. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: involvement of iNOS and COX-2. Pharmacogn Mag. 10:6–10.
  • Ray RS, Ghosh B, Rana A, Chatterjee M. 2007. Suppression of cell proliferation, induction of apoptosis and cell cycle arrest: chemopreventive activity of vanadium in vivo and in vitro. Int J Cancer. 120:13–23. doi:10.1002/ijc.22277.
  • Rivlin N, Brosh R, Oren M, Rotter V. 2011. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer. 2:466–474. doi:10.1177/1947601911408889.
  • Roy S, Das R, Ghosh B, Chakraborty T. 2018. Deciphering the biochemical and molecular mechanism underlying the in-vitro and in-vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer. Mol Carcinog. 57:700–721. doi:10.1002/mc.22792.
  • Roy S, Sil A, Chakraborty T. 2019. Potentiating apoptosis and modulation of p53, Bcl2, and Bax by a novel chrysin ruthenium complex for effective chemotherapeutic efficacy against breast cancer. J Cell Physiol. 234:4888–4909. doi:10.1002/jcp.27287.
  • Seyyedi MA, Farahnak A, Jalali M, Rokni MB. 2005. Study on glutathione S-transferase (GST) inhibition assay by triclabendazole protoscoleces (hydatid cyst; Echinococcus granulosus) and sheep liver tissue. Iran J Publ Health. 34:38–46.
  • Sharma ML, Singh B, Chandan BK, Khajuria A, Kaul A, Bani S, Banerjee SK, Gambhir SS. 1996. Actions of some flavonoids on specific and non-specific immune mechanisms. Phytomedicine. 3:191–195. doi:10.1016/S0944-7113(96)80035-3.
  • Shen Y, Lu B, Zhang S, Ma ZJ. 2014. Diterpenoid C of Radix Curcumae: an inhibitor of proliferation and inducer of apoptosis in human colon adenocarcinoma cells acting via inhibiting MAPK signaling pathway. Pharm Biol. 52:1158–1165. doi:10.3109/13880209.2013.879907.
  • Song P, Yang XZ, Yuan JQ. 2013. Cytotoxic constituents from Psoralea corylifolia. J Asian Nat Prod Res. 15:624–630. doi:10.1080/10286020.2013.793181.
  • Sudhakaran M, Sardesai S, Dose AI. 2019. Flavonoids: new frontier for immuno-regulation and breast cancer control. Antioxidants. 8:1–27. doi:10.3390/antiox8040103.
  • Waga S, Hannon G, Beach D, Stillman B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:574–578. doi:10.1038/369574a0.
  • Waldner MJ, Foersch S, Neurath MF. 2012. Interleukin-6–a key regulator of colorectal cancer development. Int J Biol Sci. 8:1248–1253. doi:10.7150/ijbs.4614.
  • Wang J, Qi L, Zheng S, Wu T. 2009. Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. Zhejiang Univ Sci B. 10:93–102. doi:10.1631/jzus.B0820238.
  • Wang JG, Wang DF, Lv BJ, Si JM. 2004. A novel mouse model for colitis-associated colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sulfate sodium. World J Gastroenterol. 10:2958–2962. doi:10.3748/wjg.v10.i20.2958.
  • Youssef KM, Ezzo AM, El-Sayed MI, Hazzaa AA, EL-Medany AH, Arafa M. 2015. Chemopreventive effects of curcumin analogs in DMH-induced colon cancer in albino rats model. Fut J Pharm Sci. 1:57–72.
  • Zhang XA, Zhang S, Yin Q, Zhang J. 2015. Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B pathway. Pharmacogn Mag. 11:404–409. doi:10.4103/0973-1296.153096.
  • Zhuo Z, Hu J, Yang X, Chen M, Lei X, Deng L, Yao N, Peng Q, Chen Z, Ye W, Zhang D. 2015. Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo. Sci Rep. 5:16185. doi:10.1038/srep16185.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.